Elevidys 1.33 × 1013 vg/mL suspension for intravenous infusion Images
Generic Name: delandistrogene moxeparvovec
This medication has been identified as Elevidys 1.33 × 1013 vg/mL suspension for intravenous infusion. It is supplied by Sarepta Therapeutics, Inc.
Elevidys is used in the treatment of Duchenne Muscular Dystrophy and belongs to the drug class miscellaneous uncategorized agents. Elevidys 1.33 × 1013 vg/mL suspension for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Elevidys
- Generic Name
- delandistrogene moxeparvovec
- Strength
- 1.33 × 1013 vg/mL suspension for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Miscellaneous uncategorized agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sarepta Therapeutics, Inc.
- National Drug Code (NDC)
See also:
Agamree
Agamree (vamorolone) is an FDA-approved treatment for Duchenne muscular dystrophy (DMD) to improve ...
Duvyzat
Duvyzat (givinostat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Viltepso
Viltepso (viltolarsen) is used for the treatment of Duchenne muscular dystrophy (DMD) treatable ...
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
Emflaza
Emflaza (deflazacort) is a corticosteroid medication used to treat a rare genetic disorder called ...
Vyondys 53
Vyondys 53 is used for Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Exondys 51
Exondys 51 is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a ...
More about Elevidys (delandistrogene moxeparvovec)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.